Regulus Therapeutics
RGLS
#9043
Rank
ยฃ76.72 M
Marketcap
ยฃ1.16
Share price
16.28%
Change (1 day)
-49.26%
Change (1 year)

Earnings for Regulus Therapeutics (RGLS)

Earnings in 2024 (TTM): -ยฃ32.07 Million

According to Regulus Therapeutics's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -ยฃ22.73 Million a decrease over its 2022 earnings that were of -ยฃ21.34 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Regulus Therapeutics from 2012 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -ยฃ32.07 Million41.07%
2023 -ยฃ22.73 Million6.51%
2022 -ยฃ21.34 Million2.53%
2021 -ยฃ20.82 Million93.59%
2020 -ยฃ10.76 Million-15.41%
2019 -ยฃ12.71 Million-64.46%
2018 -ยฃ35.76 Million-33.26%
2017 -ยฃ53.58 Million-13.98%
2016 -ยฃ62.29 Million44.77%
2015 -ยฃ43.03 Million-1.63%
2014 -ยฃ43.74 Million203.6%
2013 -ยฃ14.41 Million8.65%
2012 -ยฃ13.26 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ยฃ3.39 B-10,722.79%๐Ÿ‡ฌ๐Ÿ‡ง UK
ยฃ6.13 B-19,298.05%๐Ÿ‡ซ๐Ÿ‡ท France
ยฃ1.47 B-4,707.31%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ8.05 B-25,319.37%๐Ÿ‡ฌ๐Ÿ‡ง UK
-ยฃ0.19 Billion 469.31%๐Ÿ‡บ๐Ÿ‡ธ USA
-ยฃ0.11 Billion 224.45%๐Ÿ‡บ๐Ÿ‡ธ USA
-ยฃ6.48 Billion 20,154.30%๐Ÿ‡บ๐Ÿ‡ธ USA
-ยฃ90.86 Million 184.40%๐Ÿ‡บ๐Ÿ‡ธ USA